Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Revisiting the estimation of Covid-19 prevalence: Implications for rapid testing

Lili Zhou, View ORCID ProfileDaniel Andrés Díaz–Pachón, J. Sunil Rao
doi: https://doi.org/10.1101/2021.11.12.21266254
Lili Zhou
1Division of Biostatistics - University of Miami, Don Soffer Clinical Research Center, 1120 NW 14th St, Miami FL, 33136
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Andrés Díaz–Pachón
1Division of Biostatistics - University of Miami, Don Soffer Clinical Research Center, 1120 NW 14th St, Miami FL, 33136
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Andrés Díaz–Pachón
J. Sunil Rao
1Division of Biostatistics - University of Miami, Don Soffer Clinical Research Center, 1120 NW 14th St, Miami FL, 33136
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jrao@miami.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Surveillance studies for Covid-19 prevalence estimation are subject to sampling bias due to oversampling of symptomatic individuals and error-prone tests, particularly rapid antigen tests which are known to have high false negative rates for asymptomatic individuals. This results in naïve estimators which can be very far from the truth.In this work, we present a method that removes these two sources of error directly. Moreover, our procedure can be easily extended to the stratified error situation in which a test has very different error rate profiles for symptomatic and asymptomatic individuals as is the case for rapid antigen testing. The result is an easily understandable four-step algorithm that produces much more reliable prevalence estimates as demonstrated on data from the Israeli Ministry of Health. Thus it may re-open the debate about whether we are under-valuing rapid testing as a surveillance tool and may have policy implications in Third-World countries or disadvantaged communities where access to PCR testing may be less accessible.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data can be retrieved from https://github.com/nshomron/covidpred, and it is publicly available.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* lxz516{at}miami.edu

  • ↵† Ddiaz3{at}miami.edu

  • ↵‡ JRao{at}miami.edu

Data Availability

The data can be retrieved from https://github.com/nshomron/covidpred, and it is publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 14, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Revisiting the estimation of Covid-19 prevalence: Implications for rapid testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Revisiting the estimation of Covid-19 prevalence: Implications for rapid testing
Lili Zhou, Daniel Andrés Díaz–Pachón, J. Sunil Rao
medRxiv 2021.11.12.21266254; doi: https://doi.org/10.1101/2021.11.12.21266254
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Revisiting the estimation of Covid-19 prevalence: Implications for rapid testing
Lili Zhou, Daniel Andrés Díaz–Pachón, J. Sunil Rao
medRxiv 2021.11.12.21266254; doi: https://doi.org/10.1101/2021.11.12.21266254

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1958)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11118)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3192)
  • Geriatric Medicine (309)
  • Health Economics (565)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (788)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12739)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (337)
  • Neurology (2999)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5609)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (764)
  • Rheumatology (341)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)